Genocea Biosciences Inc. (GNCA) Declined -5.21% or -0.05 To Price $0.82 On Monday


Genocea Biosciences Inc. (GNCA) declined -5.21% or -0.05 to $0.82. It is near 451389 shares traded, which is 48.12% compare to the average total volume 937973. The market cap of GNCA is $67.32 million. The year to date change is -29.67%. The 52 week price range is from $0.79 to $7.29. Price of GNCA have changed -6.87% during last week. It have changed -22.76% over last month, -3.07% over last 3 months, -40.75% over last 6 months and -87.82% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for GNCA is 1.03. It is 25.61% above current price. The 200-day Moving Averages for GNCA is 2.24. It is 173.17% above current price. The 52-week High is 7.29. It is 789.02% from the current price. The 52-week Low is 0.79. It is -3.66% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of GNCA is 2.84 on 2018-03-29. Short % to float is 4.65%. There are some statistics of GNCA. It is has market cap $67.32 million. The share outstanding is 82.10 million. The average volume is 937973. It has 118.16M cash and 64.39M in debt. The percent of top 15 Institution holding is 58.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of GNCA is -247.10%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of GNCA is -116.66%.


Tags:

Share this post